Biomic Sciences' nasal spray was grossly contaminated with microorganisms, and FDA also found manufacturing and labeling violations.
What happened
After an inspection from June 12 through August 31, 2023, and a website review, FDA lab testing found gross microbial contamination in ION Intelligence of Nature Sinus Support Nasal Spray lot 2302081HGA. FDA also cited violations of current good manufacturing practice (CGMP) for drugs and dietary supplements and low-acid canned food registration/process filing failures. The company recalled all lots of the nasal spray and related sinus sprays to the consumer level.
What FDA found
FDA found gross microbial contamination in a lot of the nasal spray, and the firm released drug product without testing each batch for objectionable microorganisms.
21 CFR 211.165(b); 21 U.S.C. 351(a)(1)The quality control unit did not ensure drug products were made under CGMP and met identity, strength, quality, and purity specifications.
21 CFR 211.22The firm did not register as a low-acid canned food processor or file a scheduled process for Ion Gut Support.
21 CFR 108.35(c)(1)-(2); 21 CFR 113.83The firm lacked dietary supplement component specifications for identity, purity, and contamination limits.
21 CFR 111.70(b)(1)-(3)The firm did not quarantine components before using them in Ion Gut Support.
21 CFR 111.155(c)Ion Gut Support labels did not declare all ingredients and did not format the Supplement Facts panel as required.
21 U.S.C. 343(i)(2), 343(q)(5)(F); 21 CFR 101.36
What FDA wants
FDA asks the firm to correct the cited violations, clarify whether it will resume making drug products at this facility for the U.S. market, and notify FDA before marketing such products. The provided letter does not state a response deadline.
Who should pay attention
- companies making nasal sprays or other mucosal drug products
- dietary supplement brands that rely on contract manufacturers
- low-acid canned food processors and their quality teams
This is a summary. Read the original letter on fda.gov.